HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 210 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,552,000 | -49.9% | 130,290 | -48.2% | 0.01% | -52.2% |
| Q4 2017 | $5,091,000 | +180.5% | 251,300 | +140.5% | 0.02% | +155.6% |
| Q3 2017 | $1,815,000 | -62.0% | 104,500 | -62.1% | 0.01% | -43.8% |
| Q4 2015 | $4,773,000 | +14.8% | 275,400 | -11.0% | 0.02% | -27.3% |
| Q3 2015 | $4,157,000 | -60.8% | 309,600 | -34.1% | 0.02% | -65.1% |
| Q2 2015 | $10,613,000 | +253.9% | 470,000 | +123.8% | 0.06% | +173.9% |
| Q1 2015 | $2,999,000 | +216.7% | 210,000 | +181.9% | 0.02% | +187.5% |
| Q1 2014 | $947,000 | -41.6% | 74,500 | -31.1% | 0.01% | -27.3% |
| Q4 2013 | $1,622,000 | +20.0% | 108,200 | -11.6% | 0.01% | +266.7% |
| Q3 2013 | $1,352,000 | – | 122,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |